VIMTA LABS
Back to Cashflow Statement
|
VIMTA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹61 Cr | ₹88 Cr | ₹59 Cr | ₹37 Cr | ₹24 Cr |
What is the latest Cash Flow from Operating Activities ratio of VIMTA LABS ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹61 Cr |
Mar2023 | ₹88 Cr |
Mar2022 | ₹59 Cr |
Mar2021 | ₹37 Cr |
Mar2020 | ₹24 Cr |
How is Cash Flow from Operating Activities of VIMTA LABS Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹61 Cr | -30.75 | |
Mar2023 | ₹88 Cr | 48.87 | |
Mar2022 | ₹59 Cr | 58.86 | |
Mar2021 | ₹37 Cr | 52.71 | |
Mar2020 | ₹24 Cr | - |
Compare Cash Flow from Operating Activities of peers of VIMTA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VIMTA LABS | ₹2,307.8 Cr | 4.3% | 16.5% | 97.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,818.0 Cr | -4.6% | 0.7% | 10.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,628.0 Cr | -1.2% | 12.6% | 51.2% | Stock Analytics | |
CIPLA | ₹120,775.0 Cr | 0.7% | 6% | 9.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,758.0 Cr | -1.8% | -0.4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,791.0 Cr | 4% | 8.9% | -1.3% | Stock Analytics |
VIMTA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VIMTA LABS | 4.3% |
16.5% |
97.1% |
SENSEX | 0.7% |
9.6% |
10.7% |
You may also like the below Video Courses